Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Buy
16,048
+5,114
+47% +$270K 0.28% 90
2026
Q1
$603K Sell
10,934
-4,244
-28% -$230K 0.23% 104
2025
Q4
$744K Buy
15,178
+4,299
+40% +$201K 0.27% 93
2025
Q3
$470K Buy
10,879
+4,180
+62% +$163K 0.18% 115
2025
Q2
$257K Buy
+6,699
New +$256K 0.1% 160

Other funds holding GSK

Texas Bank & Trust's GSK Position: Q2 2026 in Review

Texas Bank & Trust increased its GSK (GSK) stake by 47% in Q2 2026, buying an estimated $270K and bringing the position to 16,048 shares worth $841K. The position accounts for 0.28% of the portfolio, ranked #90.

Texas Bank & Trust first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Texas Bank & Trust held 16,048 shares of GSK worth $841K as of Q2 2026.
  • Texas Bank & Trust bought 5,114 GSK shares in Q2 2026, an estimated $270K.
  • GSK made up 0.28% of Texas Bank & Trust's portfolio in Q2 2026, its #90 holding.
  • Texas Bank & Trust first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.